These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22069195)

  • 1. Advances in PET myocardial perfusion imaging: F-18 labeled tracers.
    Rischpler C; Park MJ; Fung GS; Javadi M; Tsui BM; Higuchi T
    Ann Nucl Med; 2012 Jan; 26(1):1-6. PubMed ID: 22069195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of ¹⁸F-labeled BODIPY dye as potential PET agents for myocardial perfusion imaging.
    Liu S; Li D; Shan H; Gabbaï FP; Li Z; Conti PS
    Nucl Med Biol; 2014 Jan; 41(1):120-6. PubMed ID: 24210284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moving into the next era of PET myocardial perfusion imaging: introduction of novel
    Werner RA; Chen X; Rowe SP; Lapa C; Javadi MS; Higuchi T
    Int J Cardiovasc Imaging; 2019 Mar; 35(3):569-577. PubMed ID: 30334228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research Progress on
    Mou T; Zhang X
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28358340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model.
    Nekolla SG; Reder S; Saraste A; Higuchi T; Dzewas G; Preissel A; Huisman M; Poethko T; Schuster T; Yu M; Robinson S; Casebier D; Henke J; Wester HJ; Schwaiger M
    Circulation; 2009 May; 119(17):2333-42. PubMed ID: 19380625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac PET perfusion tracers: current status and future directions.
    Maddahi J; Packard RR
    Semin Nucl Med; 2014 Sep; 44(5):333-43. PubMed ID: 25234078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 68Ga-labeled tracers for PET imaging of myocardial perfusion in pigs.
    Tarkia M; Saraste A; Saanijoki T; Oikonen V; Vähäsilta T; Strandberg M; Stark C; Tolvanen T; Teräs M; Savunen T; Green MA; Knuuti J; Roivainen A
    Nucl Med Biol; 2012 Jul; 39(5):715-23. PubMed ID: 22264857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET and SPECT Tracers for Myocardial Perfusion Imaging.
    Klein R; Celiker-Guler E; Rotstein BH; deKemp RA
    Semin Nucl Med; 2020 May; 50(3):208-218. PubMed ID: 32284107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological characterization of F-18-labeled rhodamine B, a potential positron emission tomography perfusion tracer.
    Bartholomä MD; He H; Pacak CA; Dunning P; Fahey FH; McGowan FX; Cowan DB; Treves ST; Packard AB
    Nucl Med Biol; 2013 Nov; 40(8):1043-8. PubMed ID: 24011396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of occupational radiation exposure from myocardial perfusion imaging with Rb-82 PET and Tc-99m SPECT.
    Tout D; Davidson G; Hurley C; Bartley M; Arumugam P; Bradley A
    Nucl Med Commun; 2014 Oct; 35(10):1032-7. PubMed ID: 25014243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron-emitting myocardial blood flow tracers and clinical potential.
    Schindler TH
    Prog Cardiovasc Dis; 2015; 57(6):588-606. PubMed ID: 25637500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The next generation of cardiac positron emission tomography imaging agents: discovery of flurpiridaz F-18 for detection of coronary disease.
    Yu M; Nekolla SG; Schwaiger M; Robinson SP
    Semin Nucl Med; 2011 Jul; 41(4):305-13. PubMed ID: 21624564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How many PET tracers do we need?
    Schwaiger M; Wester HJ
    J Nucl Med; 2011 Dec; 52 Suppl 2():36S-41S. PubMed ID: 22144553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase-III Clinical Trial of Fluorine-18 Flurpiridaz Positron Emission Tomography for Evaluation of Coronary Artery Disease.
    Maddahi J; Lazewatsky J; Udelson JE; Berman DS; Beanlands RSB; Heller GV; Bateman TM; Knuuti J; Orlandi C
    J Am Coll Cardiol; 2020 Jul; 76(4):391-401. PubMed ID: 32703509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Journey in evolution of nuclear cardiology: will there be another quantum leap with the F-18-labeled myocardial perfusion tracers?
    Dilsizian V; Taillefer R
    JACC Cardiovasc Imaging; 2012 Dec; 5(12):1269-84. PubMed ID: 23236979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging F-18-Labelled PET Myocardial Perfusion Tracers.
    Liga R; Neglia D
    Curr Cardiol Rep; 2020 Aug; 22(10):116. PubMed ID: 32772178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of a protocol for routine simultaneous myocardial blood flow measurement and standard myocardial perfusion imaging with rubidium-82 on a high count rate positron emission tomography system.
    Tout D; Tonge CM; Muthu S; Arumugam P
    Nucl Med Commun; 2012 Nov; 33(11):1202-11. PubMed ID: 22760302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat imaging and in vivo stability studies using [11C]-dimethyl-diphenyl ammonium, a candidate agent for PET-myocardial perfusion imaging.
    Jacobson O; Abourbeh G; Tsvirkun D; Mishani E
    Nucl Med Biol; 2013 Nov; 40(8):967-73. PubMed ID: 23999238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging.
    Bourque JM; Hanson CA; Agostini D; Bateman TM; Bax JJ; Beanlands RSB; Berman DS; Garcia EV; Heller GV; Knuuti J; Tamaki N; Udelson JE; Maddahi J
    J Nucl Cardiol; 2021 Jun; 28(3):1105-1116. PubMed ID: 33521873
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.